A UF startup based in Tampa has received approval to start clinical trials on a new form of gene therapy to treat cancerous tumors. Morphogenesis, Inc. will begin the trials on six patients with an aggressive form of skin cancer at Moffitt Cancer Center this summer. The therapeutic vaccine is injected into a cancerous tumor … Continue reading Morphogenesis to Begin Clinical Trials on Promising Cancer Therapy (WLRN)